Beneficial effects of fish and fish peptides on main metabolic syndrome associated risk factors: Diabetes, obesity and lipemia
Critical Reviews in Food Science and Nutrition · 14.10.2023 · 63 (26) · 7896-7944
DOI: 10.1080/10408398.2022.2052261 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Critical Reviews in Food Science and Nutrition, online erschienen am 17.03.2022. Verfasst von Soheila Abachi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nutrition and Functional Foods (INAF), Université Laval, Quebec, Quebec, Canada. Hauptthemen laut MEDLINE: Metabolic Syndrome, Diabetes Mellitus, Hypertension, Hyperlipidemias. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 285 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The definition of metabolic syndrome (MetS) fairly varies from one to another guideline and health organization. Per description of world health organization, occurrence of hyperinsulinemia or hyperglycemia in addition to two or more factors of dyslipidemia, hypoalphalipoproteinemia, hypertension and or large waist circumference factors would be defined as MetS. Conventional therapies and drugs, commonly with adverse effects, are used to treat these conditions and diseases. Nonetheless, in the recent decades scientific community has focused on the discovery of natural compounds to diminish the side effects of these medications. Among many available bioactives, biologically active peptides have notable beneficial effects on the management of diabetes, obesity, hypercholesterolemia, and hypertension. Marine inclusive of fish peptides have exerted significant bioactivities in different experimental in-vitro, in-vivo and clinical settings. This review exclusively focuses on studies from the recent decade investigating hypoglycemic, hypolipidemic, hypercholesterolemic and anti-obesogenic fish and fish peptides. Related extraction, isolation, and purification methodologies of anti-MetS fish biopeptides are reviewed herein for comparison purposes only. Moreover, performance of biopeptides in simulated gastrointestinal environment and structure-activity relationship along with absorption, distribution, metabolism, and excretion properties of selected oligopeptides have been discussed, in brief, to broaden the knowledge of readers on the design and discovery trends of anti-MetS compounds.Supplemental data for this article is available online at https://doi.org/10.1080/10408398.2022.2052261 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Nutrition and Functional Foods (INAF), Université Laval, Quebec, Quebec, Canada.
- Department of Food Science, Faculty of Agricultural and Food Sciences, Université Laval, Quebec, Quebec, Canada.
- Department of Medicine, Faculty of Medicine, Cardiology Axis of the Quebec Heart and Lung Institute, Quebec, Quebec, Canada.
- Laboratory of Food Processing and ElectroMembrane Processes (LTAPEM), Université Laval, Quebec, Quebec, Canada.
ORCID-Profile: Lucie Beaulieu
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Abachi, S., Pilon, G., Marette, A., Bazinet, L., & Beaulieu, L. (2023). Beneficial effects of fish and fish peptides on main metabolic syndrome associated risk factors: Diabetes, obesity and lipemia. Critical Reviews in Food Science and Nutrition, 63(26), 7896-7944. https://doi.org/10.1080/10408398.2022.2052261
Vancouver
Abachi S, Pilon G, Marette A, Bazinet L, Beaulieu L. Beneficial effects of fish and fish peptides on main metabolic syndrome associated risk factors: Diabetes, obesity and lipemia. Critical Reviews in Food Science and Nutrition. 2023;63(26):7896-7944. doi:10.1080/10408398.2022.2052261
BibTeX
@article{Abachi2023,
author = {Abachi, Soheila and Pilon, Geneviève and Marette, André and Bazinet, Laurent and Beaulieu, Lucie},
title = {Beneficial effects of fish and fish peptides on main metabolic syndrome associated risk factors: Diabetes, obesity and lipemia},
journal = {Critical Reviews in Food Science and Nutrition},
year = {2023},
volume = {63},
number = {26},
pages = {7896--7944},
doi = {10.1080/10408398.2022.2052261}
}
EUVIMED